The Vanguard Group 13D and 13G filings for Gossamer Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-01-30 9:57 pm Sale |
2024-12-31 | 13G | Gossamer Bio, Inc. GOSS |
The Vanguard Group | 10,034,149 4.420% |
-1,601,485![]() (-13.76%) |
Filing |
2024-02-13 5:06 pm Purchase |
2023-12-29 | 13G | Gossamer Bio, Inc. GOSS |
The Vanguard Group | 11,635,634 5.160% |
3,675,777![]() (+46.18%) |
Filing |
2023-02-09 11:22 am Purchase |
2022-12-30 | 13G | Gossamer Bio, Inc. GOSS |
The Vanguard Group | 7,959,857 8.430% |
2,372,398![]() (+42.46%) |
Filing |
2022-02-10 08:16 am Purchase |
2021-12-31 | 13G | Gossamer Bio, Inc. GOSS |
The Vanguard Group | 5,587,459 7.310% |
229,654![]() (+4.29%) |
Filing |
2021-02-10 10:57 am Purchase |
2020-12-31 | 13G | Gossamer Bio, Inc. GOSS |
The Vanguard Group | 5,357,805 7.060% |
1,632,737![]() (+43.83%) |
Filing |